Episode 608
TWiV 608: Daniel Griffin's COVID-19 clinical report
May 1, 202057m 12s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Daniel Griffin updates the clinical situation with COVID-19 patients, followed by analysis of the remedesivir clinical trial results, and answers listener questions.
Hosts: Vincent Racaniello and Rich Condit
Guest: Daniel Griffin
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Pulmonary embolism in COVID-19 (Emerg Inf Dis)
- Patch Study
- Remdesivir in adults with severe COVID-19 (Lancet)
- ACTT remdesivir trial (NIAID)
- Commentary on remdesivir trials (Lancet)
- FDA expected to issue remdesivir EUA (Contaigon Live)
- Recovered COVID-19 patients wrong (Korea Herald)
- Letters read on TWiV 608
- Image credit
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees.
Send your virology questions and comments to [email protected]